[1] 余靖华,甘炜坚,梁雅超,等.枳术颗粒辅助标准四联疗法治疗Hp阳性慢性萎缩性胃炎的效果[J]. 中外医学研究,2022,20(13):4
YU JH, GAN WJ, LIANG YH, et al. Effect of Zhizhu granule assisted standard quadruple therapy on Hp positive chronic atrophic gastritis[J]. Chin Foreign Med Res, 2022, 20(13): 4
[2] 邢朝富.雷贝拉唑联合莫沙比利与枳术颗粒治疗残胃炎的疗效观察[J]. 临床合理用药杂志,2012,5(18):69
XING ZF. Efficacy of rabeprazole combined with mosapride and Zhizhu granules in the treatment of residual gastritis[J]. J Clin Rational Drug Use, 2012, 5(18):69
[3] 王礼国,陈世芳,吴从吉.枳术颗粒合用奥美拉唑治疗消化性溃疡41例疗效观察[J]. 中国医学创新,2009,6(23):53
WANG LG, CHEN SF, WU CJ. Therapeutic effect of Zhishu granule combined with omeprazole on 41 cases of peptic ulcer[J]. Med Innov China, 2009, 6(23):53
[4] 黄继武.枳术颗粒联合奥美拉唑治疗消化性溃疡的疗效分析[J]. 实用心脑肺血管病杂志,2011,19(1):53
HUANG JW. Effect analysis of Zhishu granule combined with omeprazole in the treatment of peptic ulcer[J]. Pract J Cardiac Cereb Pneum Vasc Dis, 2011, 19(1):53
[5] 王志刚,卢利军.“金芪利水排石”颗粒剂与水丸剂治疗泌尿系结石的临床疗效比较[J]. 甘肃中医学院学报,2014,31(3):61
WANG ZG, LU LJ. Comparison of clinical efficacy of "Jinqi Lishuipaishi" granules and Shui pills in the treatment of urinary calculi[J]. J Gansu Univ Chin Med, 2014, 31(3):61
[6] 周骏,刘美辉,金顺福,等.高效液相色谱法测定枳术颗粒中柚皮苷的含量[J]. 中国药房,2006,17(14):1103
ZHOU J, LIU MH, JIN SF, et al. Content determination of naringin in Zhizhu granules by HPLC[J]. China Pharm, 2006, 17(14): 1103
[7] 王其华,徐云辉,濮存海,等.HPLC法测定枳术颗粒中枳实的5种黄酮类物质[J]. 药学与临床研究,2013,21(3):232
WANG QH, XUN YH, PU CH, et al. Measuring five compounds of flavonoids in immature bitter orange as monarch drug of the Zhizhu Granule by HPLC[J]. Pharm Clin Res, 2013,21(3):232
[8] 张一帆,林志航,汤秋华.一测多评法测定枳术颗粒中四种黄酮类成分的含量[J]. 海峡药学,2020,32(1):80
ZHANG YF, LIN ZH, TANG QH. Simultaneous quantitative analysis of 4 active components in Zhizhu granules using multi-components by single marker[J]. Strait Pharm J, 2020, 32(1): 80
[9] 段营辉,朱樵苏,黄澜,等.高效液相色谱法同时测定清肺抑火丸中13种成分的含量[J]. 中国医院药学杂志.2022,42(14):1399
DUAN YH, ZHU QS, HUANG L, et al. Simultaneous determination of 13 components in Oingfei Yihuo pills by high performance liquid chromatography[J]. Chin J Hosp Pharm, 2022, 42(14): 1399
[10] 刘雯,李峰,孙春亮,等.HPLC同时测定荆防颗粒中6种成分[J]. 中国实验方剂学杂志,2016,22(17):55
LIU W, LI F, SUN CL, et al. Simultaneous determination of six components in Jingfang granule by HPLC[J]. Chin J Exp Tradit Med Form, 2016, 22(17): 55
[11] 刘统治, 金国娥. 浅谈李东垣枳术丸及现代临床运用[J]. 中医药临床杂志,2015,27(3):357
LIU TZ, JIN GE. Discussion of the modern clinical applications of Zhizhu pills of LI Dongyuan[J]. Clin J Tradit Chin Med, 2015, 27(3): 357
[12] 丁玲,于志峰,周加林.加味枳术颗粒治疗糖尿病胃轻瘫的疗效观察[J]. 中国医院用药评价与分析,2018,18(3):349
DING L, YU ZF, ZHOU JL. Observation on efficacy of Jiaweizhizhu granules in treatment of diabetic gastroparesis[J]. Eval Anal Drug-Use Hosp Chin, 2018, 18(3): 349
[13] 臧彬如, 单国顺, 贾天柱,等. UPLC法测定生、制白术配伍枳术丸中10种成分[J]. 中成药, 2020, 42(4):960
ZHANG BR, SHAN GS, JIA TZ, et al. Determination of ten constituents in raw and processed Atractylodes macrocephala compatible Zhizhu pills by UPLC[J]. Chin Tradit Pat Med, 2020, 42(4): 960
[14] 庞茜茜,岳威冶,刘克勤,等.雪梨止咳糖浆中11个成分的含量测定及化学计量学分析[J]. 中国药房,2023,34(1):62
PANG QQ, YUE WY, LIU KQ, et al. Content determination and chemometric analysis of 11 components in Xueli Zhike syrup[J]. China Pharm, 2023, 34(01): 62
[15] 黄砚,刁灏瑒,张雁.克咳片中8个成分的含量测定[J]. 药物分析杂志,2020,40(2):337
HUANG Y, DIAO HY, ZHANG Y. Determination of 8 constituents in Keke tablets[J]. Chin J Pharm Anal, 2020, 40(2): 337
[16] 方达锋,马恩耀,冯冲,等.基于主成分分析与聚类分析的不同产地白芍质量评价研究[J]. 特种经济动植物,2023,26(1):14
FANG DF, MA EY, FENG C, et al. Study on quality evaluation of Paeony from different producing areas based on principal component analysis and cluster analysis[J]. Spec Econ Anim Plants, 2023, 26(1):14
[17] 李卓群,王海丽,贵书琪,等.小儿感冒舒颗粒HPLC指纹图谱建立与化学模式识别[J]. 中国现代应用药学,2021,38(22):2820
LI ZQ, WANG HL, GUI SQ, et al. HPLC fingerprint establishment and chemistry pattern recognition of Xiaoer Ganmaoshu Granules[J]. Chin J Mod Appl Pharm, 2021, 38(22): 2820
[18] 项锋,叶继锋,侯齐书.基于PCA和PLS-DA算法的不同生长阶段贯叶金丝桃药材HPLC指纹图谱研究[J]. 药物分析杂志,2020,40(3):568
XIANG F, YE JF, HOU QS. Study on HPLC fingerprint of Hyperici Perforati Herba at different growth stage based on PCA and PLS-DA[J]. Chin J Pharm Anal, 2020, 40(3): 568
[19] 何佳,黄文康,马相锋,等.基于主成分分析与PLS-DA分析研究浙麦冬道地性与等级评价标准[J]. 中国药学杂志,2021,56(4):285
HE J, HUANG WK, MA XF, et al. Geoherbalism and grand evaluation of Zhejiang Ophiopogon japonicas based on PCA and PLS-DA[J]. Chin Pharm J, 2021, 56(4): 285
[20] 王国锋.基于指纹图谱及偏最小二乘法-判别分析(PLS-DA)评价肝爽颗粒的质量[J]. 中国药师,2022,25(10):1865
WANG GF. Quality evaluation of Ganshuang granules by HPLC fingerprint and PLS-DA[J]. China Pharm, 2022, 25(10): 1865
[21] 杨玉环,张灵煜,郭秋平,等.枳实、枳壳的生物活性成分及其应用研究进展[J]. 食品与药品,2021,23(5):476
YANG YH, ZHANG LY, GUO QP, et al. Bioactive components of Fructus Aurantii Immaturus and Fructus Aurantii and their application[J]. Food Drug, 2021, 23(5): 476
[22] 钟民勇,乔日发,魏飞亭,等.枳壳、枳实胃肠动力作用及其机制的研究概况[J]. 江西中医药,2021,52(12):68
ZHONG MY, QIAO RF, WEI FT, et al. Research overview on gastrointestinal motility and its mechanism of Fructus Aurantii and Fructus Aurantii[J]. Jiangxi J Tradit Chin Med, 2021, 52(12): 68
[23] 赵文龙,吴慧,单国顺,等.麸炒白术“减酮减燥,增酯增效”炮制理论的再印证[J]. 中国中药杂志,2013,38(20):3493
ZHAO WL, WU H, SHAN GS, et al. Verification of processing theory of" reducing ketone and dryness, and increasing ester and effect" for bran-fried atractylodes[J]. China J Chin Mater Med, 2013, 38(20): 3493
[24] 曾丽华,伍振峰,王芳,等.中药制剂质量均一性的现状问题及保证策略研究[J]. 中国中药杂志,2017,42(19):3826
ZENG LH, WU ZF, WANG F, et al. Status,problems and warranty strategy of quality uniformity for traditional Chinese medicine preparations[J]. China J Chin Mater Med, 2017, 42(19): 3826
[24] 陆超颖,王佳丽,王洪兰,等.不同基原积实药材的质量差异评价研究[J]. 中草药,2022,53(14):4493
LU CY, WANG JL, WANG HL, et al. Study on quality difference of Aurantii Fructus Immaturus from different otigins[J]. Chin Tradit Herb Drugs, 2022, 53 (14): 4493
[26] 刘现磊,李琨,张辉,等.市售丹参配方颗粒的UPLC指纹图谱及化学模式识别研究[J]. 药物分析杂志,2022,42(11):2000
LIU XL, LI K, ZHANG H, et al. UPLC fingerprint and chemical pattern recognition study on commercial available Danshen formula granules[J]. Chin J Pharm Anal, 2022, 42(11): 2000
